| 000 | 01104 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250516223649.0 | ||
| 264 | 0 | _c20150515 | |
| 008 | 201505s 0 0 eng d | ||
| 022 | _a1875-9114 | ||
| 024 | 7 |
_a10.1002/phar.1463 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHighsmith, Kaitlin N | |
| 245 | 0 | 0 |
_aCarfilzomib and pomalidomide: recent advances in the treatment of multiple myeloma. _h[electronic resource] |
| 260 |
_bPharmacotherapy _cSep 2014 |
||
| 300 |
_a927-40 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMultiple Myeloma _xdrug therapy |
| 650 | 0 | 4 |
_aOligopeptides _xadverse effects |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aThalidomide _xadverse effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aChen, Sheree E | |
| 700 | 1 | _aHorowitz, Sandy | |
| 773 | 0 |
_tPharmacotherapy _gvol. 34 _gno. 9 _gp. 927-40 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/phar.1463 _zAvailable from publisher's website |
| 999 |
_c24025978 _d24025978 |
||